In our current study we observe extreme hypermethylation of the AWT1 promoter, an epigenetic mark generally associated with robust gene silencing, in myeloid-derived hematological cancer cell lines and primary samples. The gene discussed is WT1; the disease is hematopoietic and lymphoid cell neoplasm.